Author:
Mora Jaume,Cruz Ofelia,Gala Sandra,Navarro Ramon
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Neurology (clinical),Oncology
Reference47 articles.
1. Allen, J.C., Aviner, S., Yates, A.J., Boyett, J.M., Cherlow, J.M., Turski, P.A., Epstein F., and Finlay, J.L. (1998) Treatment of high-grade spinal cord astrocytoma of childhood with “8-in-1” chemotherapy and radiotherapy: A pilot study of CCG-945. Children's Cancer Group. J. Neurosurg.88, 215-220.
2. Blaney, S., Berg, S.L., Pratt, C., Weitman, S., Sullivan, J., Luchtman-Jones, L., and Bernstein, M. (2001) A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group study. Clin. Cancer Res.7, 32-37.
3. Bomgaars, L., Berg, S.L., and Blaney, S.M. (2001) The development of camptothecin analogs in childhood cancers. Oncologist6, 506-516.
4. Bomgaars, L., Kerr, J., Berg, S., Kuttesch, J., Klenke, R., and Blaney, S.M. (2006) A phase I study of irinotecan administered on a weekly schedule in pediatric patients. Pediatr. Blood Cancer46, 50-55.
5. Bouffet, E., Pierre-Kahn, A., Marchal, J.C., Jouvet, A., Kalifa, C., Choux, M., Dhellemmes, P., Guerin, J., Tremoulet, M., and Mottolese, C. (1998) Prognostic factors in pediatric spinal cord astrocytoma. Cancer83, 2391-2399.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献